The UAB Department of Psychiatry is currently recruiting participants in the Birmingham area for a research study evaluating the safety, efficacy, and maintenance of effect of an investigational medication in people with major depressive disorder. Some participants may also be struggling with insomnia.
To qualify, you must:
- be 18-74 years of age
- be diagnosed with depression
- have taken antidepressants in the past that did not work well for you
- currently take an antidepressant medication but still have symptoms of MDD
The study will consist of two parts. In Part 1, participants will receive the investigational
medication or placebo for up to 6 weeks. Participants who complete Part 1 will have the option to participate in Part 2. In Part 2, participants will be subject to a second double blind phase with variable duration comparing the investigational medication to placebo for up to 16 weeks or more. Compensation will be provided for each completed session.
Qualified patients may receive study-required medical care and investigational study medication at no cost. The study will not pay for other medical care or current medication(s) needed to support personal daily health care routines.